Aquestive Therapeutics Inc AQST:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:48 PM EST
4.89quote price arrow up+0.05 (+1.03%)
Volume
17,737
Close
4.84quote price arrow down-0.54 (-10.04%)
Volume
1,137,092
52 week range
3.10 - 8.06
Loading...
  • Open5.40
  • Day High5.47
  • Day Low4.75
  • Prev Close5.38
  • 52 Week High8.06
  • 52 Week High Date12/15/20
  • 52 Week Low3.10
  • 52 Week Low Date07/30/21

Key Stats

  • Market Cap188.23M
  • Shares Out38.89M
  • 10 Day Average Volume0.58M
  • Dividend-
  • Dividend Yield-
  • Beta3.61
  • YTD % Change-9.53

KEY STATS

  • Open5.40
  • Day High5.47
  • Day Low4.75
  • Prev Close5.38
  • 52 Week High8.06
  • 52 Week High Date12/15/20
  • 52 Week Low3.10
  • 52 Week Low Date07/30/21
  • Market Cap188.23M
  • Shares Out38.89M
  • 10 Day Average Volume0.58M
  • Dividend-
  • Dividend Yield-
  • Beta3.61
  • YTD % Change-9.53

RATIOS/PROFITABILITY

  • EPS (TTM)-1.72
  • P/E (TTM)-2.81
  • Fwd P/E (NTM)-2.78
  • EBITDA (TTM)-40.968M
  • ROE (TTM)-3,347.45%
  • Revenue (TTM)41.88M
  • Gross Margin (TTM)68.98%
  • Net Margin (TTM)-152.73%
  • Debt To Equity (MRQ)-72.94%

EVENTS

  • Earnings Date03/07/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aquestive Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Aquestive Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing and commercializing differentiated products which leverage PharmFilm. Its late-stage product pipeline focused on the treatment of central nervous system (CNS), diseases and an earlier stage pipeline including treatment of anaphylaxis. Its commercialized licensed product is Suboxone, a sublingual film formulation of buprenorphine and naloxone, for the treatment of opioid dependence....
Santo Costa J.D.
Non-Executive Chairman
Keith Kendall
President
Daniel Barber
Chief Operating Officer
Ernest Toth CPA., J.D.
Chief Financial Officer
A. Mark Schobel
Chief Technology Officer
Address
30 Technology Dr
Warren, NJ
07059-5166
United States

Top Peers

SYMBOLLASTCHG%CHG
MEIP
MEI Pharma Inc
2.51-0.19-7.04%
HROW
Harrow Health Inc
9.35-0.38-3.91%
ESPR
Esperion Therapeutics Inc
5.25-3.72-41.47%
CDXC
Chromadex Corp
4.35-0.26-5.64%
DRRX
DURECT Corp
0.8956-0.0782-8.0304%